Provided by Tiger Fintech (Singapore) Pte. Ltd.

China SXT Pharmaceuticals

4.31
-1.2271-22.15%
Post-market: 4.30-0.0084-0.19%19:59 EST
Volume:117.64K
Turnover:567.86K
Market Cap:2.19M
PE:-0.15
High:5.50
Open:5.50
Low:4.27
Close:5.54
Loading ...
Nov 01, 2024

Correspondence

Form CORRESP - Correspondence
Aug 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Aug 14, 2024

Annual Report

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
May 31, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 09, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 09, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 12, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Aug 01, 2023

Annual Report

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
May 20, 2023

[Rev.]Annual Report

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
Apr 13, 2023

Correspondence

Form CORRESP - Correspondence
Mar 29, 2023

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Mar 29, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 30, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Aug 25, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jul 18, 2022

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]